Important safety information: The information contained in this link is not intended as a substitute for medical advice, and should be used for educational purposes only. Patients are advised to consult with their physician or health care professionals if they have further questions.
- What is Paclitaxel?
- What is it used for?
- How does it work?
- What are the advantages of Paclitaxel over other cancer therapies?
- How is it taken?
- What are the common side effects?
- Who should not take Paclitaxel?
Biolyse Pharma Paclitaxel is a natural molecule extracted from the twigs and needles of Taxus canadensis. This plant is the predominant representative of the Taxacea family in Northeastern America and is closely related to Taxus brevifolia prevailing in Northwestern America. Taxus canadensis is an evergreen shrub growing in a natural environment and is free of any herbicide or pesticide when harvested.
It is used in chemotherapy to treat aggressive forms of lung and breast cancer.
Paclitaxel has a different mechanism of action from other drugs. Essentially, it interferes with the division and proliferation of cells, by affecting the cell’s microtubules (which act as a backbone) during cell mitosis (division). Paclitaxel stabilizes the microtubules, preventing the cancer cells from dividing and multiplying. Eventually, the cell ‘dies of old age’.
Paclitaxel for Injection is all natural, and is less expensive than alternative cancer treatments currently available on the market. Fabricated from a renewable resource, we can be secure in the knowledge that Biolyse is doing its part to conserve this precious yew species. Finally, it is projected that Paclitaxel for Injection will be used in combination with other treatments to reduce the occurrence of multi-drug resistance (MDR) by the cancer cells.
Paclitaxel for Injection may only be dispensed by a physician as it is administered intravenously.
The side effects of Paclitaxel for Injection may include nausea and vomiting, hair loss, mouth sores, allergic reactions, irritation of the injection site, numbness in the hands or the feet, joint and muscle pain, and effects to the heart, blood vessels and blood cell counts which may result in an increased likelihood of developing infections and a reduced ability of the blood to clot. These side effects are generally temporary and dissipate following the treatment.
Women of childbearing potential should avoid becoming pregnant and breast feeding during therapy with Paclitaxel for Injection. As there are no studies to date on pregnant or nursing women, it is not clear if nursing mothers will excrete related substances in breast milk to their children.